Top

Published in:

Open Access 01-04-2015 | Research Article

The negative regulators of Wnt pathway—DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival

Authors: Jarosław Paluszczak, Joanna Sarbak, Magdalena Kostrzewska-Poczekaj, Katarzyna Kiwerska, Małgorzata Jarmuż-Szymczak, Reidar Grenman, Daniela Mielcarek-Kuchta, Wanda Baer-Dubowska

Published in: Tumor Biology | Issue 4/2015

Abstract

The deregulation of Wnt signaling has recently emerged as one of the drivers of head and neck cancers. This is frequently related to the methylation of several antagonists of this pathway. This study aimed at the assessment of the profile of methylation of Wnt pathway antagonists and the determination of the prognostic value of the methylation of selected genes in oral carcinomas. The methylation of DACH1, DKK1, LKB1, PPP2R2B, RUNX3, SFRP2, and WIF-1 was analyzed in 16 oral squamous cell carcinoma cell lines using the methylation-specific polymerase chain reaction. The methylation of selected genes was further analyzed in tumor sections from 43 primary oral carcinoma patients. The analysis of oral carcinoma cell lines showed very frequent methylation of SFRP2 and WIF-1 and also a less frequent methylation of DACH1 and DKK1. On the other hand, RUNX3 was methylated only in one cell line, while LKB1 and PPP2R2B were not methylated in any of the cell lines. The biallelic methylation of DKK1 correlated with the low level of expression of this gene. Further evaluation of the methylation of DACH1, DKK1, and WIF1 in a clinical patient group confirmed the frequent methylation of WIF1 and intermediate or low frequency of methylation of DACH1 or DKK1, respectively. Importantly, the methylation of WIF-1 correlated with shorter survival in oral cancer patients. Overall, the methylation of the antagonists of Wnt pathway is frequently detected in oral squamous cell carcinomas. The methylation of WIF1 may be considered a prognostic marker in oral cancers.

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi:10.3322/caac.21166.CrossRefPubMed

Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11(1):9–22. doi:10.1038/nrc2982.CrossRefPubMed

Paluszczak J, Baer-Dubowska W. Epigenetic diagnostics of cancer—the application of DNA methylation markers. J Appl Genet. 2006;47(4):365–75. doi:10.1007/bf03194647.CrossRefPubMed

Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, et al. The way Wnt works: components and mechanism. Growth Factors. 2013;31(1):1–31. doi:10.3109/08977194.2012.752737.CrossRefPubMed

Lea IA, Jackson MA, Li X, Bailey S, Peddada SD, Dunnick JK. Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis. 2007;28(9):1851–8. doi:10.1093/carcin/bgm176.CrossRefPubMedPubMedCentral

Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 2013;3(7):770–81. doi:10.1158/2159-8290.CD-12-0537.CrossRefPubMed

Sogabe Y, Suzuki H, Toyota M, Ogi K, Imai T, Nojima M, et al. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma. Int J Oncol. 2008;32(6):1253–61.PubMed

Yeh KT, Chang JG, Lin TH, Wang YF, Chang JY, Shih MC, et al. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer. Int J Oncol. 2003;23(4):1001–7.PubMed

Paluszczak J, Hemmerling D, Kostrzewska-Poczekaj M, Jarmuz-Szymczak M, Grenman R, Wierzbicka M, et al. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas. J Oral Pathol Med off pub Int Assoc Oral Pathol Am Acad Oral Pathol. 2014. doi:10.1111/jop.12178.

10.

Pannone GBP, Santoro A, Franco R, Aquino G, Longo F, Botti G. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep. 2010;24:1035–41. doi:10.3892/or_00000952.PubMed

11.

Towle R, Truong D, Hogg K, Robinson WP, Poh CF, Garnis C. Global analysis of DNA methylation changes during progression of oral cancer. Oral Oncol. 2013;49(11):1033–42. doi:10.1016/j.oraloncology.2013.08.005.CrossRefPubMed

12.

Diaz Prado SM, Medina Villaamil V, Aparicio Gallego G, Blanco Calvo M, Lopez Cedrun JL, Sironvalle Soliva S, et al. Expression of Wnt gene family and frizzled receptors in head and neck squamous cell carcinomas. Virchows Arch Int J pathol. 2009;455(1):67–75. doi:10.1007/s00428-009-0793-z.CrossRef

13.

Ravindran G, Devaraj H. Aberrant expression of beta-catenin and its association with DeltaNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma. Clin Oral Investig. 2012;16(4):1275–88. doi:10.1007/s00784-011-0605-0.CrossRefPubMed

14.

Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene. 2000;19(28):3220–4. doi:10.1038/sj.onc.1203703.CrossRefPubMed

15.

Rhee CS, Sen M, Lu D, Wu C, Leoni L, Rubin J, et al. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene. 2002;21(43):6598–605. doi:10.1038/sj.onc.1205920.CrossRefPubMed

16.

Ishida K, Ito S, Wada N, Deguchi H, Hata T, Hosoda M, et al. Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia. Mol Cancer. 2007;6:62. doi:10.1186/1476-4598-6-62.CrossRefPubMedPubMedCentral

17.

Alvarado CG, Maruyama S, Cheng J, Ida-Yonemochi H, Kobayashi T, Yamazaki M, et al. Nuclear translocation of beta-catenin synchronized with loss of E-cadherin in oral epithelial dysplasia with a characteristic two-phase appearance. Histopathology. 2011;59(2):283–91. doi:10.1111/j.1365-2559.2011.03929.x.CrossRefPubMed

18.

Duan Y, Fan M. Lentivirus-mediated gene silencing of beta-catenin inhibits growth of human tongue cancer cells. J Oral Pathol Med Off Pub Int Assoc Oral Pathol Am Acad Oral Pathol. 2011;40(8):643–50. doi:10.1111/j.1600-0714.2011.01007.x.

19.

Chang HW, Lee YS, Nam HY, Han MW, Kim HJ, Moon SY, et al. Knockdown of beta-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines. Cell Signal. 2013;25(4):839–47. doi:10.1016/j.cellsig.2012.12.020.CrossRefPubMed

20.

Iwai SYA, Harada C, Hamada M, Katagiri W, Nakazawa M, Yura Y. Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells. Int J Oncol. 2010;37(5):1095–103. doi:10.3892/ijo_00000761.CrossRefPubMed

21.

Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996;93(18):9821–6.CrossRefPubMedPubMedCentral

22.

Esteller M, Avizienyte E, Corn PG, Lothe RA, Baylin SB, Aaltonen LA, et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene. 2000;19(1):164–8. doi:10.1038/sj.onc.1203227.CrossRefPubMed

23.

Yan W, Wu K, Herman JG, Brock MV, Fuks F, Yang L, et al. Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer. Epigenetics. 2013;8(12):1373–83. doi:10.4161/epi.26781.CrossRefPubMedPubMedCentral

24.

Tan J, Lee PL, Li Z, Jiang X, Lim YC, Hooi SC, et al. B55beta-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer. Cancer Cell. 2010;18(5):459–71. doi:10.1016/j.ccr.2010.10.021.CrossRefPubMed

25.

Song HJ, Shim KN, Joo YH, Kim SE, Jung SA, Yoo K. Methylation of the tumor suppressor gene RUNX3 in human gastric carcinoma. Gut liver. 2008;2(2):119–25. doi:10.5009/gnl.2008.2.2.119.CrossRefPubMedPubMedCentral

26.

Supic G, Kozomara R, Jovic N, Zeljic K, Magic Z. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers. Oral Dis. 2011;17(8):794–800. doi:10.1111/j.1601-0825.2011.01838.x.CrossRefPubMed

27.

Marsit CJ, McClean MD, Furniss CS, Kelsey KT. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer J Int cancer. 2006;119(8):1761–6. doi:10.1002/ijc.22051.CrossRef

28.

de Freitas C-SM, Stur E, Agostini LP, de Podesta JR, de Oliveira JC, Soares MS, et al. Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort. Mol Biol Rep. 2012;39(12):10111–9. doi:10.1007/s11033-012-1885-4.CrossRef

29.

Ekizoglu S, Dalay N, Karaman E, Akdeniz D, Ozaydin A, Buyru N. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer. Transl Res J Lab Clin Med. 2013;162(2):122–9. doi:10.1016/j.trsl.2013.06.001.CrossRef

30.

Katz J, Jakymiw A, Ducksworth MK, Stewart CM, Bhattacharyya I, Cha S, et al. CIP2A expression and localization in oral carcinoma and dysplasia. Cancer Biol Ther. 2010;10(7):694–9. doi:10.4161/cbt.10.7.12895.CrossRefPubMedPubMedCentral

31.

Zhang S, Feng XL, Shi L, Gong CJ, He ZJ, Wu HJ, et al. Genome-wide analysis of DNA methylation in tongue squamous cell carcinoma. Oncol Rep. 2013;29(5):1819–26. doi:10.3892/or.2013.2309.PubMed

32.

Gao F, Huang C, Lin M, Wang Z, Shen J, Zhang H, et al. Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas. J Cancer Res Clin Oncol. 2009;135(5):739–47. doi:10.1007/s00432-008-0508-x.CrossRefPubMed

33.

Kudo Y, Tsunematsu T, Takata T. Oncogenic role of RUNX3 in head and neck cancer. J Cell Biochem. 2011;112(2):387–93. doi:10.1002/jcb.22967.CrossRefPubMed

34.

Popov VM, Wu K, Zhou J, Powell MJ, Mardon G, Wang C, et al. The Dachshund gene in development and hormone-responsive tumorigenesis. Trends Endocrinol Metab TEM. 2010;21(1):41–9. doi:10.1016/j.tem.2009.08.002.CrossRefPubMed

35.

Ogoshi K, Kasamatsu A, Iyoda M, Sakuma K, Yamatoji M, Sakamoto Y, et al. Dickkopf-1 in human oral cancer. Int J Oncol. 2011;39(2):329–36. doi:10.3892/ijo.2011.1046.PubMed

36.

Yoshino M, Suzuki M, Tian L, Moriya Y, Hoshino H, Okamoto T, et al. Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers. Int J Oncol. 2009;35(5):1201–9.PubMed

Title: The negative regulators of Wnt pathway—DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival
Authors: Jarosław Paluszczak
Joanna Sarbak
Magdalena Kostrzewska-Poczekaj
Katarzyna Kiwerska
Małgorzata Jarmuż-Szymczak
Reidar Grenman
Daniela Mielcarek-Kuchta
Wanda Baer-Dubowska
Publication date: 01-04-2015
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 4/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-014-2913-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2015

Correlation between squamous cell carcinoma of the lung and human papillomavirus infection and the relationship to expression of p53 and p16

Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma

LASS2/TMSG1 inhibits growth and invasion of breast cancer cell in vitro through regulation of vacuolar ATPase activity

Role of Yes-associated protein 1 in gliomas: pathologic and therapeutic aspects

Prognostic role of serum carbohydrate antigen 19-9 levels in patients with resectable hepatocellular carcinoma

RETRACTED ARTICLE: Augmented TGFβ receptor signaling induces apoptosis of pancreatic carcinoma cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer